The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2022 | Bringing novel agents to the frontline setting in myeloma
In this video, Mattia D’Agostino, MD, University of Turin, Turin, Italy, shares some insights into current and future treatment approaches in multiple myeloma, and the excitement around bringing novel agents to the frontline setting. Dr D’Agostino also highlights treatment options for transplant-eligible and elderly patients, and concludes by mentioning the promise of immunotherapies, including CAR-T therapy and bispecific antibodies. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.
